Highest Dividend yield of Pharmaceuticals and Biotechnology stocks




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Dividend yield of Pharmaceuticals and Biotechnology companies ordered from highest ( 1.54% average).

Company Dividend Payout Country
GlaxoSmithKline4.85%266.67%UK
AstraZeneca4.72%77.39%UK
AbbVie Inc4.14%61.69%USA
Teva Pharmaceutical3.86%124.06%Israel
Novo-Nordisk B3.77%62.94%Denmark
Pfizer3.75%69.19%USA
Sanofi3.60%53.27%France
Takeda Pharm3.45%177.32%Japan
Novartis (REGD)3.44%65.06%Switzerland
Roche Hldgs (GENUS)3.31%61.55%Switzerland
Merck & Co2.85%68.61%USA
Orion B2.79%73.86%Finland
Bristol Myers Squibb2.75%56.12%USA
Gilead Sciences2.67%17.08%USA
Johnson & Johnson2.62%49.46%USA
Amgen Corp2.61%37.36%USA
Daiichi Sankyo2.54%43.69%Japan
Lilly (Eli) & Co2.51%67.10%USA
KYORIN Holdings2.45%31.36%Japan
Eisai2.38%17.14%Japan
Kaken Pharmaceutical2.37%27.73%Japan
Abbott Laboratories2.35%94.64%USA
TORRENT PHARMACEUTIC2.20%26.84%India
Astellas Pharmaceuti2.18%29.65%Japan
Sawai Pharmaceutical2.14%27.82%Japan
Miraca Holdings2.08%-125.42%Japan
Mitsubishi Tanabe Ph2.08%47.84%Japan
Otsuka Holdings1.96%58.61%Japan
Shanghai Pharmaceuti1.94%30.71%China
Tsumura & Co1.92%34.95%Japan
Grifols S.A. Cl B1.90%34.83%Spain
China Medical System1.73%45.83%China
Alfresa Holdings1.68%21.00%Japan
UCB Cap1.64%43.31%Belgium and Lux.
China Traditional Ch1.64%31.58%China
Medipal Holdings1.62%22.03%Japan
Mochida Pharm1.62%33.37%Japan
Santen Pharm1.61%17.87%Japan
Kissei Pharm1.58%27.02%Japan
Ono Pharmaceutical1.53%75.75%Japan
Grifols1.51%34.83%Spain
Kyowa Hakko Kirin1.49%73.46%Japan
Novozymes A/S1.48%35.78%Denmark
Shanghai Fosun Pharm1.42%30.40%China
Suzuken1.42%18.03%Japan
CSL1.39%42.71%Australia
Chugai Seiyaku1.39%52.97%Japan
Lonza Grp Ag N1.35%47.53%Switzerland
Sinopharm Group (H)1.34%29.45%China
Hisamitsu Pharmaceut1.34%38.59%Japan
Wockhardt1.33%32.33%India
Divis Laboratories1.32%23.90%India
Chr. Hansen Holding1.25%44.03%Denmark
Kalbe Farma1.24%43.52%Indonesia
Shionogi1.24%31.75%Japan
Recordati1.17%32.11%Italy
CSPC Pharmaceutical1.16%39.29%China
Richter1.12%21.28%Hungary
Taisho Pharmaceutica1.09%35.43%Japan
Hikma Pharmaceutical1.07%30.67%UK
Merck Kgaa1.02%21.78%Germany
Ipsen1.01%30.91%France
Kobayashi Pharmaceut0.98%30.09%Japan
Piramal Enterprises0.95%27.27%India
Rohto Pharmaceutical0.93%23.81%Japan
Sumitomo Dainippon P0.91%23.39%Japan
Sino Biopharm (P Chi0.90%25.00%China
Aspen Pharmacare Hol0.88%23.12%South Africa
Yuhan0.85%16.07%Korea
China National Accor0.79%14.23%China
Zoetis0.79%22.95%USA
Perrigo Company plc0.78%10.25%USA
Luye Pharma Group (P0.73%13.79%China
Cadila Healthcare0.73%21.29%India
Hanmi Science0.71%15.62%Korea
Dr Reddys Labs0.70%14.42%India
Hanmi Pharmaceutical0.58%11.72%Korea
Actelion Hldg N0.55%20.55%Switzerland
Nippon Shinyaku0.53%34.13%Japan
Lupin0.51%14.54%India
Aurobindo Pharmaceut0.39%7.56%India
Shire0.39%12.93%UK
Cipla0.34%10.34%India
Allergan0.29%1.25%USA
Glenmark Pharmaceuti0.22%6.83%India
Sun Pharmaceuticals0.15%4.96%India
Qiagen Nv0.00%0.00%Germany
Valeant Pharmaceutic0.00%0.00%Canada
3SBio (P Chip)0.00%0.00%China
Guangzhou Baiyunsha0.00%0.00%China
Genmab0.00%0.00%Denmark
H. Lundbeck0.00%0.00%Denmark
Peptidream0.00%0.00%Japan
Celltrion Inc0.00%0.00%Korea
Samsung Biologics0.00%0.00%Korea
OBI Pharma0.00%0.00%Taiwan
Alexion Pharm0.00%0.00%USA
Alkermes plc0.00%0.00%USA
Alnylam Pharmaceutic0.00%0.00%USA
Biogen0.00%0.00%USA
BioMarin Pharm0.00%0.00%USA
Bioverativ0.00%0.00%USA
Celgene Corp0.00%0.00%USA
Endo International p0.00%0.00%USA
Illumina Inc0.00%0.00%USA
Incyte0.00%0.00%USA
Jazz Pharmaceuticals0.00%0.00%USA
Mallinckrodt plc0.00%0.00%USA
Mylan N.V.0.00%0.00%USA
Quintiles Transnatio0.00%0.00%USA
Regeneron Phar0.00%0.00%USA
Vertex Pharm0.00%0.00%USA
Medivation0.00%0.00%USA
Adcock Ingram Holdin2.74%88.51%South Africa
Meda A1.57%21.55%Sweden
GlaxoSmithKline Phar1.51%111.59%India

 


 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.